We are live on ! Find out more
SWTX

SpringWorks Therapeutics
SWTX

Delisted

SWTX was delisted on the 30th of June, 2025.

Back to rankings

222 hedge funds and large institutions have $3.53B invested in SpringWorks Therapeutics in 2025 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 83 increasing their positions, 69 reducing their positions, and 132 closing their positions.

New
Increased
Maintained
Reduced
Closed

839% more call options, than puts

Call options by funds: $465M | Put options by funds: $49.6M

100% more funds holding in top 10

Funds holding in top 10: 9 → 18 (+9)

20% more repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 69

7% more capital invested

Capital invested by funds: $3.29B → $3.53B (+$235M)

0.13% more ownership

Funds ownership: 99.46% → 99.59% (+0.13%)

27% less funds holding

Funds holding: 306 → 222 (-84)

61% less first-time investments, than exits

New positions opened: 51 | Existing positions closed: 132

Holders
222
Holders Change
-84
Holders Change %
-27.45%
% of All Funds
2.92%
Holding in Top 10
18
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+100%
% of All Funds
0.24%
New
51
Increased
83
Reduced
69
Closed
132
Calls
$465M
Puts
$49.6M
Net Calls
+$416M
Net Calls Change
+$248M

Top Buyers

Rank Fund Capital Flow
1
GCL
Glazer Capital LLC
New York
+$183M
2
Fidelity International
Fidelity International
Bermuda
+$134M
3
TAL
TIG Advisors LLC
New York
+$105M
4
BCM
Beryl Capital Management
California
+$94.2M
5
MF
Magnetar Financial
Illinois
+$91.3M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$498M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$112M
3
PCH
Polar Capital Holdings
United Kingdom
-$77.2M
4
WP
Woodline Partners
California
-$76M
5
Pictet Asset Management
Pictet Asset Management
Switzerland
-$73.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$341M +$45.1M +1,014,573 +16%
Vanguard Group
2
Vanguard Group
Pennsylvania
$335M +$2.15M +48,423 +0.7%
GCL
3
Glazer Capital LLC
New York
$193M +$183M +4,107,199 New
Fidelity International
4
Fidelity International
Bermuda
$142M +$134M +3,013,959 New
State Street
5
State Street
Massachusetts
$141M +$3.45M +77,659 +3%
TAL
6
TIG Advisors LLC
New York
$123M +$105M +2,359,400 +937%
Goldman Sachs
7
Goldman Sachs
New York
$107M +$73.4M +1,649,354 +263%
BCM
8
Beryl Capital Management
California
$99.5M +$94.2M +2,117,575 New
MF
9
Magnetar Financial
Illinois
$96.5M +$91.3M +2,052,642 New
FTCM
10
First Trust Capital Management
Illinois
$91.3M +$86.5M +1,943,767 New
Norges Bank
11
Norges Bank
Norway
$85.3M +$43.7M +981,611 +118%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$84.1M +$3.29M +73,997 +4%
Barclays
13
Barclays
United Kingdom
$76.7M +$31.3M +703,796 +76%
Citigroup
14
Citigroup
New York
$74.8M +$64.5M +1,449,188 +1,020%
NAM
15
Nexpoint Asset Management
Texas
$74.4M +$70.4M +1,583,116 New
UOC
16
UBS O'Connor
Illinois
$65.1M +$59.9M +1,346,549 +3,456%
AllianceBernstein
17
AllianceBernstein
Tennessee
$63.5M +$55.8M +1,253,369 +1,291%
AA
18
AQR Arbitrage
Connecticut
$62M +$58.7M +1,319,782 New
Morgan Stanley
19
Morgan Stanley
New York
$58.6M +$15.7M +352,208 +39%
AAM
20
Alpine Associates Management
Florida
$54M +$42.2M +949,500 +476%
JP Morgan Chase
21
JP Morgan Chase
New York
$54M +$48.3M +1,086,550 +1,742%
Principal Financial Group
22
Principal Financial Group
Iowa
$47.1M -$2.7M -60,709 -6%
PCM
23
Pentwater Capital Management
Florida
$47M +$22.2M +500,000 +100%
WA
24
Whitebox Advisors
Minnesota
$37.4M +$35.4M +795,191 New
TC
25
Trium Capital
United Kingdom
$37M +$35M +787,459 New
1
2 3 4 5

SWTX Hedge Fund Activity: Q2 2025 in Review

222 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q2 2025, worth a combined $3.53B — up 7.1% from $3.29B a quarter earlier.

Sellers outnumbered buyers: 132 funds closed out of SWTX and 51 opened new positions — a net loss of 81 holders — while 69 trimmed existing stakes and 83 added.

The largest buyer was Glazer Capital LLC, opening a new position worth an estimated $183M. The largest seller was Fidelity Investments, cutting an estimated $498M.

  • 222 institutional investors held SpringWorks Therapeutics (SWTX) as of Q2 2025, down from 306 in Q1 2025.
  • Funds reported $3.53B of SpringWorks Therapeutics stock for Q2 2025, up 7.1% quarter-over-quarter.
  • 51 funds opened new SpringWorks Therapeutics positions in Q2 2025 and 132 closed out, a net change of -81 holders.
  • The largest SpringWorks Therapeutics buyer in Q2 2025 was Glazer Capital LLC, an estimated $183M added.
  • The largest SpringWorks Therapeutics seller in Q2 2025 was Fidelity Investments, an estimated $498M sold.

Based on aggregated 13F filings for Q2 2025.